BB Biotech AG (XSWX:BION) Scaled Net Operating Assets: 0.82 (As of Mar. 2026)


XSWX:BION BB Biotech AG XSWX:BION
33 GF Score
Price CHF47.80
! 3 Warning Signs
View Full Analysis

What is BB Biotech AG Scaled Net Operating Assets?

BB Biotech AG XSWX:BION +2.14% 33 Scaled Net Operating Assets is 0.82 as of Mar. 2026. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BB Biotech AG's operating assets for the quarter that ended in Mar. 2026 was CHF2,286.2 Mil. BB Biotech AG's operating liabilities for the quarter that ended in Mar. 2026 was CHF7.9 Mil. BB Biotech AG's Total Assets for the quarter that ended in Dec. 2025 was CHF2,785.8 Mil. Therefore, BB Biotech AG's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.82.

XSWX:BION
33GF Score
BB Biotech AG XSWX:BION
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BB Biotech AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(2687.543-6.974)/2407.399
=1.11

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Balance Sheet Cash And Cash Equivalents
=2785.759 - 98.216
=2687.543

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6.974 - 0 - 0
=6.974

BB Biotech AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(2286.211-7.86)/2785.759
=0.82

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Balance Sheet Cash And Cash Equivalents
=2641.182 - 354.971
=2286.211

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=7.86 - 0 - 0
=7.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.82 mean?
BB Biotech AG (XSWX:BION) has a Scaled Net Operating Assets of 0.82 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on BB Biotech AG and its competitors.
Is BB Biotech AG's Scaled Net Operating Assets too high?
BB Biotech AG's current Scaled Net Operating Assets is 0.82. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Scaled Net Operating Assets compare to VRTX and REGN?
BB Biotech AG's Scaled Net Operating Assets of 0.82 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current Scaled Net Operating Assets is 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Scaled Net Operating Assets of 0.82. The current Scaled Net Operating Assets is 0.82. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Scaled Net Operating Assets is 0.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score

Get the complete analysis for XSWX:BION

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF47.80
Price